Deep Bio's AI Support for Cancer Diagnosis has been Designated as an Innovative Product by the Korean Public Procurement Service

SEOUL, South Korea (PRWEB) July 25, 2022 -- Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that its AI

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,India ,Korea , ,Stanford Medical School ,Korean Public Procurement Service ,Harvard Dana Farber Cancer Institute ,Bio Inc ,Ministry Of Food ,Innovative Product Designation Program ,Samds In Vitro Diagnostics Software ,Deep Bio ,Prostate Pro ,Innovative Product ,Fast Track ,Innovative Products ,Public Procurement ,Public Procurement Market ,Sun Woo Kim ,Whole Slide Image ,Drug Safety ,Cancers Journal ,Digital Medicine ,Vitro Diagnostics Software ,Medical Device ,